Differences
This shows you the differences between two versions of the page.
Next revision | Previous revision | ||
sgpt_alt [2025/01/27 11:08] – created admin | sgpt_alt [2025/01/27 11:26] (current) – admin | ||
---|---|---|---|
Line 1: | Line 1: | ||
+ | |[[clinical_biochemistry_section|Home]]|[[clinical_biochemistry|]]|[[examination_procedures|]]| | ||
+ | |||
+ | SGPT (ALT) Examination Procedure | ||
+ | |||
**1.Purpose of examination: | **1.Purpose of examination: | ||
* ALT estimation from serum or plasma by NADH (without Pyridoxal Phosphate) Method. | * ALT estimation from serum or plasma by NADH (without Pyridoxal Phosphate) Method. | ||
Line 11: | Line 15: | ||
* Type of Sample: Serum, | * Type of Sample: Serum, | ||
* Type of container and additives: Plain without any additives | * Type of container and additives: Plain without any additives | ||
- | * Patient Preparation: | + | * Patient Preparation: |
* Stability: At Room temperature 18°–28°C (64°–82°F) stability ≤ 24 hours | * Stability: At Room temperature 18°–28°C (64°–82°F) stability ≤ 24 hours | ||
* Handling and transport: As per Primary Sample collection manual | * Handling and transport: As per Primary Sample collection manual | ||
Line 20: | Line 24: | ||
**5.Required reagents:** | **5.Required reagents:** | ||
- | | + | * R1.L-alanine (66.820 g/L) |
- | | + | β-NADH (0.305 g/L) |
- | | + | lactate dehydrogenase (5.000 KU/L) |
- | * R2. L-alanine | + | * R2. L-alanine |
- | α-ketoglutaric acid (13.150 g/L) | + | α-ketoglutaric acid (13.150 g/L) |
**6.Reagent Handling** | **6.Reagent Handling** | ||
* Remove any air bubbles present in the reagents with a new applicator stick, or allow the reagents to settle at the appropriate storage temperature to allow the bubbles to dissipate. To minimize volume depletion, do not use a transfer pipette to remove bubbles | * Remove any air bubbles present in the reagents with a new applicator stick, or allow the reagents to settle at the appropriate storage temperature to allow the bubbles to dissipate. To minimize volume depletion, do not use a transfer pipette to remove bubbles | ||
Line 73: | Line 77: | ||
ALT present in the sample catalyzes the transfer of the amino group from L-alanine to α-ketoglutarate, | ALT present in the sample catalyzes the transfer of the amino group from L-alanine to α-ketoglutarate, | ||
absorbance at 340 nm due to the oxidation of NADH to NAD+. | absorbance at 340 nm due to the oxidation of NADH to NAD+. | ||
+ | |||
**10.Sample Preparation: | **10.Sample Preparation: | ||
* Required SampleVolume: | * Required SampleVolume: | ||
* Temperature: | * Temperature: | ||
* Take 150-200µl of the sample from Primary tube to the secondary aliquot. Write the sample ID on the aliquot. | * Take 150-200µl of the sample from Primary tube to the secondary aliquot. Write the sample ID on the aliquot. | ||
+ | |||
**11.Procedure to run Patient sample** | **11.Procedure to run Patient sample** | ||
- Press Patient order | - Press Patient order | ||
Line 85: | Line 91: | ||
**12.Performance Characteristics: | **12.Performance Characteristics: | ||
- | **Linearity: | + | * **Linearity: |
- | Automated Dilution Protocol: | + | Automated Dilution Protocol: |
- | The system performs a 1:5 dilution of the sample and automatically calculates the concentration by multiplying the result by the dilution factor. | + | |
**Manual Dilution Procedure: | **Manual Dilution Procedure: | ||
Dilute the specimen with saline (0.85% to 0.90% NaCl). Enter the dilution factor in the Patient or Control order screen | Dilute the specimen with saline (0.85% to 0.90% NaCl). Enter the dilution factor in the Patient or Control order screen | ||
- | **The limit of detection (LOD):** 4 U/L | + | * **The limit of detection (LOD):** 4 U/L |
- | **The limit of quantification(LOQ): | + | |
- | **Unit:** U/L | + | |
**Normal and critical ranges:** | **Normal and critical ranges:** | ||
Line 115: | Line 120: | ||
**16.Recording of observation: | **16.Recording of observation: | ||
- | Software backup | + | * Software backup |
- | Machine raw data | + | |
**17.Storage & Disposal of waste:** Follow storage & discard procedure | **17.Storage & Disposal of waste:** Follow storage & discard procedure | ||
+ | |||
**18.Environmental & Safety control:** | **18.Environmental & Safety control:** | ||
* For in vitro diagnostic use | * For in vitro diagnostic use | ||
* Do not use component before the expiration date | * Do not use component before the expiration date | ||
* Do not mix material from different kit lot number. | * Do not mix material from different kit lot number. | ||
+ | |||
**19.References: | **19.References: | ||
- US department of labor, Occupational safety and health administration. | - US department of labor, Occupational safety and health administration. | ||
Line 129: | Line 137: | ||
+ | |**Printed copy of this document is considered uncontrolled.** It should be compared with controlled electronic copy before use| | ||
+ | |||
+ | ^ Name of Laboratory : Laboratory Services Sir T. Hospital (LSSTH), | ||
+ | ^Document No.1^**Document Name**: SGPT (ALT) Examination Procedure^**Unique ID**:LSSTH /BIOCHEM/ SOP-5^^ | ||
+ | ^Issue No. : 01^Issue Date : | ||
+ | ^Amend No.^ Amend Date ^Prepared by: Section Incharge^Approved & Issued by: HOD, |